3,5-diiodothyropropionic acid

Generic Name: 3,5-diiodothyropropionic acid

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₂I_₂O_₄

CAS Number: 1158-10-7

Unique Ingredient Identifier: 1HTO2X0SJ9

Background: DITPA has been investigated in Congestive Heart Failure.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Phase 2

Terminated

Conditions: Congestive Heart Failure

Interventions: Drug: DITPA

First Posted Date: 2002-03-28

Last Posted Date: 2013-11-05

Lead Sponsor: US Department of Veterans Affairs

Target Recruit Count: 150

Registration Number: NCT00032643

Locations: 🇺🇸
Southern Arizona VA Health Care System, Tucson, Arizona, United States
🇺🇸
Ralph H Johnson VA Medical Center, Charleston, Charleston, South Carolina, United States
🇺🇸
VA Medical Center, Minneapolis, Minneapolis, Minnesota, United States

and more 4 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy